Gain Therapeutics, Inc. (GANX)

NGM – Real Time Price. Currency in USD

1.80

-0.02 (-1.10%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

55K

140K

Cost of goods sold

-94K

-84K

-80K

-64K

Gross Profit

-94K

-84K

-25K

76K

Operating expenses (excl. COGS)

-19M

-20M

-22M

-18M

Operating Income

-19M

-20M

-22M

-18M

Non-operating income, total

-589K

476K

65K

279K

Pretax income

-19M

-20M

-22M

-17M

Equity in earnings

Taxes

-861K

-537K

-79K

-93K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-20M

-22M

-18M

Gain Therapeutics, Inc. (GANX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Gain Therapeutics, Inc. (GANX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Gain Therapeutics, Inc. (GANX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Gain Therapeutics, Inc. (GANX)

Income Statement (Annual)

Income Statement (Annual)